Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6.
Stamos, J.L., Chu, M.L., Enos, M.D., Shah, N., Weis, W.I.(2014) Elife 3: e01998-e01998
- PubMed: 24642411 
- DOI: 10.7554/eLife.01998
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Glycogen synthase kinase-3 (GSK-3) is a key regulator of many cellular signaling pathways. Unlike most kinases, GSK-3 is controlled by inhibition rather than by specific activation. In the insulin and several other signaling pathways, phosphorylation ...